You are here

  • Home
  • Archive
  • Volume 12, Issue 8
  • Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab

Article metrics

Article menu
Case report
Case report of fatal immune-mediated myocarditis following treatment with davoceticept (ALPN-202), a PD-L1-dependent CD28 costimulator and dual PD-L1/CTLA-4 checkpoint inhibitor, in combination with pembrolizumab

 

Online download statistics by month:

Online download statistics by month: August 2024 to November 2025

AbstractFullPdf
Aug 2024670672239
Sep 2024222223136
Oct 2024228228114
Nov 202415015178
Dec 202419920180
Jan 202511711778
Feb 2025133133102
Mar 2025131132104
Apr 202510710965
May 202510210253
Jun 2025636355
Jul 2025110
Nov 2025110
Total212421331104